Literature DB >> 8215962

Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia.

R B King1.   

Abstract

OBJECTIVE: To determine pain patterns and relationships in patients with herpes zoster and postherpetic neuralgia before and after topical application of aspirin dissolved in chloroform applied to the painful skin surface.
DESIGN: A consecutive series of 42 patients examined and treated in a uniform manner and followed up until their pain subsided or this management mode failed.
SETTING: An ambulatory referral private practice. PATIENTS: All patients had pain due to herpes zoster or postherpetic neuralgia and were referred for management of severe pain. None refused. INTERVENTION: Topical application of crushed aspirin tablets dissolved in chloroform. OUTCOME MEASURES: Short-Form McGill Pain Questionnaire.
RESULTS: All patients reported substantially decreased pain promptly after treatment, with maximum relief at 20 to 30 minutes and lasting 2 to 4 hours. Patients gradually decreased the use of aspirin in chloroform as pain abated.
CONCLUSIONS: Topical aspirin dissolved in chloroform is an effective means of reducing pain due to herpes zoster and postherpetic neuralgia in most patients. The locus of pain origin and analgesia induced by topical aspirin is most likely at cutaneous free-nerve ending pain receptors. The mechanism responsible for the analgesic properties of aspirin is probably not the same as that responsible for its anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215962     DOI: 10.1001/archneur.1993.00540100041012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  Results from the translation and adaptation of the Iranian Short-Form McGill Pain Questionnaire (I-SF-MPQ): preliminary evidence of its reliability, construct validity and sensitivity in an Iranian pain population.

Authors:  Farhad Adelmanesh; Ali Arvantaj; Hassan Rashki; Seyedmehdi Ketabchi; Ali Montazeri; Gholamreza Raissi
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2011-11-10

Review 2.  AMPK: An emerging target for modification of injury-induced pain plasticity.

Authors:  Theodore J Price; Gregory Dussor
Journal:  Neurosci Lett       Date:  2013-07-03       Impact factor: 3.046

Review 3.  Analgesia in the elderly. Practical treatment recommendations.

Authors:  M P Drage; S A Schug
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 4.  Herpes zoster and postherpetic neuralgia. Optimal treatment.

Authors:  R W Johnson
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 5.  Treatment of postherpetic neuralgia: an update.

Authors:  G E Kanazi; R W Johnson; R H Dworkin
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 6.  Tolerability of treatments for postherpetic neuralgia.

Authors:  Mark W Douglas; Robert W Johnson; Anthony L Cunningham
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Natural history of pain following herpes zoster.

Authors:  Hans Gustav Thyregod; Michael C Rowbotham; Michelle Peters; Jessica Possehn; Marlene Berro; Karin Lottrup Petersen
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

Review 8.  Topical delivery of salicylates.

Authors:  Soo Chin Yeoh; Choon Fu Goh
Journal:  Drug Deliv Transl Res       Date:  2021-04-28       Impact factor: 4.617

Review 9.  Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.

Authors:  Kathleen Hempenstall; Turo J Nurmikko; Robert W Johnson; Roger P A'Hern; Andrew S C Rice
Journal:  PLoS Med       Date:  2005-07-26       Impact factor: 11.069

Review 10.  Post herpetic neuralgia: a review.

Authors:  M J Griffin; F A Chambers; R MacSullivan
Journal:  Ir J Med Sci       Date:  1998 Apr-Jun       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.